Approval · Notice of Compliance 28631 · 2022
DENAGARD: Notice of Compliance 28631
Issued July 22, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28631
- Date
- July 22, 2022
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug substance manufacturing and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DENAGARD | 00860735 | Cancelled Post Market |
Medicinal ingredients
- TIAMULIN FUMARATE 2.2 G per 100G